Qty:1
  • List Price: $17.50
  • Save: $5.69 (33%)
FREE Shipping on orders over $35.
In Stock.
Ships from and sold by Amazon.com.
Gift-wrap available.
From Alchemy To Ipo: The ... has been added to your Cart
FREE Shipping on orders over $35.
Condition: Used: Good
Comment: This item is gently used in good or better condition. If it is a textbook it may not have supplements. It may have some moderate wear and possibly include previous ownerâ€TMs name, some markings and/or is a former library book. We ship within 1 business day and offer no hassle returns. Big Hearted Books shares its profits with schools, churches and non-profit groups throughout New England. Thank you for your support!
Have one to sell? Sell on Amazon
Flip to back Flip to front
Listen Playing... Paused   You're listening to a sample of the Audible audio edition.
Learn more
See all 2 images

From Alchemy To Ipo: The Business Of Biotechnology Paperback – April 12, 2001


See all 3 formats and editions Hide other formats and editions
Amazon Price New from Used from
School & Library Binding
"Please retry"
Paperback
"Please retry"
$11.81
$4.63 $0.01
Best%20Books%20of%202014
$11.81 FREE Shipping on orders over $35. In Stock. Ships from and sold by Amazon.com. Gift-wrap available.


Frequently Bought Together

From Alchemy To Ipo: The Business Of Biotechnology + The Billion Dollar Molecule: One Company's Quest for the Perfect Drug
Price for both: $24.23

Buy the selected items together

NO_CONTENT_IN_FEATURE

Holiday Deals in Books
Holiday Deals in Books
Find deals for every reader in the Holiday Deals in Books store, featuring savings of up to 50% on cookbooks, children's books, literature & fiction, and more.

Product Details

  • Paperback: 272 pages
  • Publisher: Basic Books; 1 edition (April 12, 2001)
  • Language: English
  • ISBN-10: 073820482X
  • ISBN-13: 978-0738204826
  • Product Dimensions: 6 x 0.7 x 9 inches
  • Shipping Weight: 15.2 ounces (View shipping rates and policies)
  • Average Customer Review: 4.1 out of 5 stars  See all reviews (12 customer reviews)
  • Amazon Best Sellers Rank: #457,512 in Books (See Top 100 in Books)

Editorial Reviews

Review

"A fascinating glimpse inside the life-and-death business of biotechnology. A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth." -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers "From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can." -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen"

About the Author

Cynthia Robbins-Roth, Ph.D., is the founder of BioVenture Consultants, which provides strategic planning and financial assessment to biotech start-ups, pharmaceutical companies, and venture-capital firms. Her biotech column appears regularly in Forbes magazine, and Forbes ASAP recently named her one of the top twenty-five biotech all-stars of 1999. She lives in San Mateo, California.

More About the Author

Discover books, learn about writers, read author blogs, and more.

Customer Reviews

4.1 out of 5 stars
Share your thoughts with other customers

Most Helpful Customer Reviews

17 of 22 people found the following review helpful By A Customer on August 25, 2001
Format: Paperback
to quote another user: "The author's expertise in science, finance, management strategy, and journalism..." the author can write decently and she may know about biotech (hard to judge for me not being a scientist)...BUT her knowledge about management strategy and finance is limited at best...that wouldn't be so bad if she were to stick to write about science...however, she thinks she knows about finance and strategy...who wants to read about strategy should stick with hamel, pralahad, porter etc., who wants to read about finance (valuation) should stick with copeland et al, and who wants to read about ipos should try articles by jay ritter.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
4 of 4 people found the following review helpful By dk76 on May 27, 2002
Format: Paperback
I'll be starting a biomedical engineering Ph.D. program in the fall and have read recently a few books on the biotech subject. This one gave the clearest picture of the biotech industries, the companies in them, how to manage and finance them, as well as how to recognize solid biotech companies for investing purposes. A quick and entertaining read for anyone interested in the business behind biotechnology.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
3 of 3 people found the following review helpful By MA on April 2, 2013
Format: Paperback Verified Purchase
Well written and interesting intro to the Biotech industry, but it was written over 10 years ago. Several sections badly need updating: For example, Many of the companies mentioned no longer exist or have been bought out by larger pharma. Also, there have been huge advances in Human genetics since the book was written - the Human Genome project is largely complete and we have seen the results of this in the multitude of GWAS studies that have been published in recent years, giving us insights into many complex diseases. Nevertheless, the book is interesting and I enjoyed reading it.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
2 of 2 people found the following review helpful By SKB Greystone on March 5, 2005
Format: Paperback
I read From Alchemy to IPO for an MBA course on entrepreneurialism in the pharmaceutical industry. Given my background (undergraduate business, financial analyst role, limited in-depth scientific knowledge), I found this book to be a very useful and balanced guide to both the business and technical aspects of biotechnology.

Robbins-Roth includes enough information on initial public offerings (IPOs) and merger activity among biotech firms to warm the hearts of the most resolute business student, but the drug discovery and development process is also covered in sufficient detail to give the lay reader an understanding for the operational challenges faced by firms in this sector.

Add to this the competent yet necessarily superficial descriptions of more esoteric terms such as monoclonal antibodies and combinatorial chemistry, and you have a solid text that covers the industry and its ongoing challenges very well.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
1 of 1 people found the following review helpful By Willey Bob on June 15, 2013
Format: Paperback Verified Purchase
I believe this book is a little dated being published more than 10 years ago, but the concepts for the most part are still very valid. I wish it would have been able to talk more about how the internet has affected business, and the recent recession has affected the biotech industry.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
1 of 1 people found the following review helpful By Samu on November 13, 2010
Format: Paperback Verified Purchase
Just started reading this and i must say its already surpassed my expectations, and i think I'm only on page 50 or so. The author uses a multifaceted approach to present the facts which makes it all the more captivating. Biotech deals with improvement of quality of life and it's nice to have examples of this along the way.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again

What Other Items Do Customers Buy After Viewing This Item?